| 1 |
Jagadeesh D, Woda BA, Draper J, et al. Post transplant lymphoproliferative disorders: risk,classification, and therapeutic recommendations[J]. Curr Treat Options Oncol, 2012, 13 (1): 122-126.
|
| 2 |
Dierickx D, Tousseyn T, Gheysens O. How I treat posttransplant lymphoproliferative disorders[J]. Blood, 2015, 126 (20): 2274-2283.
|
| 3 |
Horwitz SM, Zelenetz AD, Gordon LI, et al. NCCN guidelines insights: non-hodgkin's lymphomas, version 3.2016[J]. J Natl Compr Canc Netw, 2016, 14 (9): 1067-1079.
|
| 4 |
Abramson JS, Feldman T, Kroll-desrosiers AR, et al. Peripheral T-cell lymphomas in a large US multicenter cohort: prognostication in the modern era including impact of frontline therapy[J]. Ann Oncol, 2014, 25 (11): 2211-2217.
|
| 5 |
Shouval R, Labopin M, Bondi O, et al. Prediction of Allogeneic Hematopoietic Stem-Cell Transplantation Mortality 100 Days After Transplantation Using a Machine Learning Algorithm: A European Group for Blood and Marrow Transplantation Acute Leukemia Working Party Retrospective Data Mining Study[J]. J Clin Oncol, 2015, 33 (21): 2392-2398.
|
| 6 |
Corradini P, Vitolo U, Rambaldi A, et al. Intensified chemo-immunotherapy with or without stem cell transplantation in newly diagnosed patients with peripheral T-cell lymphoma[J]. Leukemia, 2014, 28(9): 1885-1891.
|
| 7 |
张钦，邹秉含，楼晓，等. 异基因造血干细胞移植后EB病毒感染的危险因素及预后分析[J]. 中华内科杂志，2016，55(8):619-623.
|
| 8 |
Luo L, Zhang L, Cai B, et al. Post-transplant lymphoproliferative disease after allogeneic hematopoietic stem cell transplantation: a single-center experience [J]. Ann Transplant, 2014 (19): 6-12.
|
| 9 |
鲍协炳，朱倩，仇惠英，等. 异基因造血干细胞移植后EBV病毒感染临床危险因素分析[J]. 中华血液学杂志, 2016，37(2):138-143.
|
| 10 |
Singavi AK, Harrington AM, Fenske TS. Post-transplant lymphoproliferative disorders[J]. Cancer Treat Res, 2015 (165): 305-327.
|
| 11 |
Choquet S, Trappe R, Leblond V, et al. CHOP-21 for the treatment of post-transplant lymphoproliferative disorders (PTLD) following solid organ transplantation[J]. Haematologica, 2007, 92 (2): 273-274.
|
| 12 |
Trappe R, Oertel S, Leblond V, et al. Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial[J]. Lancet Oncol, 2012, 13 (2): 196-206.
|
| 13 |
Kuriyama T, Kawano N, Yamashita K, et al. Successful treatment of Rituximab-resistant Epstein-Barr virus-associated post-transplant lymphoproliferative disorder using R-CHOP[J]. J Clin Exp Hematop, 2014, 54 (2): 149-153.
|